@article{f345c3254c554451a45f2ff85168f52b,
title = "Proteolysis of Ambra1 during apoptosis has a role in the inhibition of the autophagic pro-survival response",
abstract = "Under stress conditions, pro-survival and pro-death processes are concomitantly activated and the final outcome depends on the complex crosstalk between these pathways. In most cases, autophagy functions as an early-induced cytoprotective response, favoring stress adaptation by removing damaged subcellular constituents. Moreover, several lines of evidence suggest that autophagy inactivation by the apoptotic machinery is a crucial event for cell death execution. Here we show that apoptotic stimuli induce a rapid decrease in the level of the autophagic factor Activating Molecule in Beclin1-Regulated Autophagy (Ambra1). Ambra1 degradation is prevented by concomitant inhibition of caspases and calpains. By both in vitro and in vivo approaches, we demonstrate that caspases are responsible for Ambra1 cleavage at the D482 site, whereas calpains are involved in complete Ambra1 degradation. Finally, we show that Ambra1 levels are critical for the rate of apoptosis induction. RNA interference-mediated Ambra1 downregulation further sensitizes cells to apoptotic stimuli, while Ambra1 overexpression and, more efficiently, a caspase non-cleavable mutant counteract cell death by prolonging autophagy induction. We conclude that Ambra1 is an important target of apoptotic proteases resulting in the dismantling of the autophagic machinery and the accomplishment of the cell death program.",
keywords = "Ambra1, apoptosis, autophagy, calpains, caspases",
author = "V. Pagliarini and E. Wirawan and A. Romagnoli and F. Ciccosanti and G. Lisi and S. Lippens and F. Cecconi and Fimia, {G. M.} and P. Vandenabeele and M. Corazzari and M. Piacentini",
note = "Funding Information: Acknowledgements. We thank Dr. A Bredan for editing the paper. This work was supported by a grant from European Community (APO-SYS Health F4-2007-200767) to MP, Ministry for Health of Italy ({\textquoteleft}Ricerca Corrente{\textquoteright} to MP and GMF, {\textquoteleft}Ricerca Finalizzata RF07.103{\textquoteright} to GMF and {\textquoteleft}Ricerca Oncologica n. ONC-ORD 35/ 07{\textquoteright} to GMF), AIRC and Compagnia di San Paolo di Torino to MP, AIRC (MFAG-11743) to MC. SL holds a postdoctoral fellowship from the FWO. The doctoral fellowship of EW has been supported by Ghent University grants (BOF 2001-GOA 12050502 en BOF 2005-GOA 01GC0205) and by the Flemish Government Methusalem project BOF09/01M00709. Research in the Vandenabeele group is funded by European grants (FP6 ApopTrain, MRTN-CT-035624; FP7 EC RTD Integrated Project, Apo-Sys, FP7-200767; Euregional PACT II), Belgian grants (Interuniversity Attraction Poles, IAP 6/18), Flemish grants (Research Foundation Flanders, FWO G.0875.11 and FWO G.0973.11), Ghent University grants (MRP, GROUP-ID consortium) and grants from Flanders Institute for Biotechnology (VIB). PV holds a Methusalem grant (BOF09/01M00709) from the Flemish Government. FC is partly supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC), the Telethon Foundation, the Italian Ministry of Health and the Italian Ministry of University and Research.",
year = "2012",
month = sep,
doi = "10.1038/cdd.2012.27",
language = "English",
volume = "19",
pages = "1495--1504",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Springer Nature",
number = "9",
}